CNBC February 2, 2025
Ashley Capoot

Key Points

– Tech investor Reid Hoffman is tackling drug development with his new startup Manas AI, which he launched with oncologist Dr. Siddhartha Mukherjee this week.

– Manas will use artificial intelligence to try and accelerate the drug discovery process, starting with new treatments for aggressive cancers.

– The company has raised $24.6 million in seed funding, led by General Catalyst and Hoffman.

LinkedIn co-founder and venture capitalist Reid Hoffman became a billionaire from his business social-working company, and has made lucrative bets on companies including Airbnb and Zynga while also backing nuclear fusion startup Helion Energy.

Now Hoffman is diving into the health care, which he describes as “wondrous and terrifying,” with his latest startup, Manas AI.

...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Technology
OpenAI CEO Sam Altman: Company Considering ‘Different Open-Source Strategy’
Chinese AI app DeepSeek was downloaded by millions. Deleting it might come next
Forget Billion-Dollar Companies—Will AI Create Billion-Dollar People?
The future of cardiac monitoring: AI-powered wearables in practice
Microsoft Unveils Surface Copilot+ PCs

Share This Article